nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0948	0.216	CbGbCtD
Tiotropium—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0719	0.164	CbGbCtD
Tiotropium—CYP3A4—Betamethasone—ankylosing spondylitis	0.0617	0.14	CbGbCtD
Tiotropium—CYP3A4—Prednisolone—ankylosing spondylitis	0.0608	0.139	CbGbCtD
Tiotropium—CYP3A4—Prednisone—ankylosing spondylitis	0.0575	0.131	CbGbCtD
Tiotropium—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0564	0.128	CbGbCtD
Tiotropium—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0359	0.0817	CbGbCtD
Tiotropium—Intraocular pressure increased—Dexamethasone—ankylosing spondylitis	0.00994	0.0177	CcSEcCtD
Tiotropium—Intraocular pressure increased—Betamethasone—ankylosing spondylitis	0.00994	0.0177	CcSEcCtD
Tiotropium—Intraocular pressure increased—Prednisone—ankylosing spondylitis	0.00865	0.0154	CcSEcCtD
Tiotropium—Glaucoma—Prednisolone—ankylosing spondylitis	0.00696	0.0124	CcSEcCtD
Tiotropium—Ulcerative stomatitis—Methotrexate—ankylosing spondylitis	0.00689	0.0123	CcSEcCtD
Tiotropium—Glaucoma—Triamcinolone—ankylosing spondylitis	0.0064	0.0114	CcSEcCtD
Tiotropium—Glaucoma—Methylprednisolone—ankylosing spondylitis	0.00638	0.0114	CcSEcCtD
Tiotropium—Glaucoma—Dexamethasone—ankylosing spondylitis	0.0058	0.0103	CcSEcCtD
Tiotropium—Glaucoma—Betamethasone—ankylosing spondylitis	0.0058	0.0103	CcSEcCtD
Tiotropium—Cataract—Triamcinolone—ankylosing spondylitis	0.00506	0.00902	CcSEcCtD
Tiotropium—Glaucoma—Prednisone—ankylosing spondylitis	0.00505	0.00901	CcSEcCtD
Tiotropium—Candida infection—Triamcinolone—ankylosing spondylitis	0.0046	0.0082	CcSEcCtD
Tiotropium—Cataract—Betamethasone—ankylosing spondylitis	0.00459	0.00819	CcSEcCtD
Tiotropium—Cataract—Dexamethasone—ankylosing spondylitis	0.00459	0.00819	CcSEcCtD
Tiotropium—Herpes zoster—Methotrexate—ankylosing spondylitis	0.00422	0.00753	CcSEcCtD
Tiotropium—Skin ulcer—Methotrexate—ankylosing spondylitis	0.00409	0.00728	CcSEcCtD
Tiotropium—Gingivitis—Methotrexate—ankylosing spondylitis	0.00405	0.00723	CcSEcCtD
Tiotropium—Hypercholesterolaemia—Prednisone—ankylosing spondylitis	0.00402	0.00717	CcSEcCtD
Tiotropium—Cataract—Prednisone—ankylosing spondylitis	0.004	0.00713	CcSEcCtD
Tiotropium—Dry skin—Prednisolone—ankylosing spondylitis	0.00349	0.00621	CcSEcCtD
Tiotropium—Glossitis—Methotrexate—ankylosing spondylitis	0.00345	0.00615	CcSEcCtD
Tiotropium—Dry skin—Betamethasone—ankylosing spondylitis	0.00291	0.00518	CcSEcCtD
Tiotropium—Dry skin—Dexamethasone—ankylosing spondylitis	0.00291	0.00518	CcSEcCtD
Tiotropium—Mouth ulceration—Methotrexate—ankylosing spondylitis	0.00288	0.00513	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.00281	0.00501	CcSEcCtD
Tiotropium—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00254	0.00453	CcSEcCtD
Tiotropium—Visual impairment—Prednisolone—ankylosing spondylitis	0.00253	0.00452	CcSEcCtD
Tiotropium—Dry skin—Prednisone—ankylosing spondylitis	0.00253	0.00452	CcSEcCtD
Tiotropium—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.00247	0.00441	CcSEcCtD
Tiotropium—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.00247	0.00441	CcSEcCtD
Tiotropium—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00243	0.00432	CcSEcCtD
Tiotropium—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00242	0.00431	CcSEcCtD
Tiotropium—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.0024	0.00428	CcSEcCtD
Tiotropium—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00237	0.00423	CcSEcCtD
Tiotropium—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00235	0.00419	CcSEcCtD
Tiotropium—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00233	0.00415	CcSEcCtD
Tiotropium—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00226	0.00402	CcSEcCtD
Tiotropium—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00219	0.0039	CcSEcCtD
Tiotropium—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00218	0.00389	CcSEcCtD
Tiotropium—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00218	0.00388	CcSEcCtD
Tiotropium—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00216	0.00385	CcSEcCtD
Tiotropium—Vision blurred—Prednisolone—ankylosing spondylitis	0.00216	0.00385	CcSEcCtD
Tiotropium—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00216	0.00384	CcSEcCtD
Tiotropium—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00215	0.00384	CcSEcCtD
Tiotropium—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00212	0.00377	CcSEcCtD
Tiotropium—Visual impairment—Betamethasone—ankylosing spondylitis	0.00212	0.00377	CcSEcCtD
Tiotropium—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00211	0.00377	CcSEcCtD
Tiotropium—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.0021	0.00375	CcSEcCtD
Tiotropium—Angioedema—Prednisolone—ankylosing spondylitis	0.00209	0.00373	CcSEcCtD
Tiotropium—Syncope—Prednisolone—ankylosing spondylitis	0.00205	0.00366	CcSEcCtD
Tiotropium—Eye disorder—Betamethasone—ankylosing spondylitis	0.00205	0.00366	CcSEcCtD
Tiotropium—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00205	0.00366	CcSEcCtD
Tiotropium—Back pain—Triamcinolone—ankylosing spondylitis	0.00204	0.00363	CcSEcCtD
Tiotropium—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00201	0.00359	CcSEcCtD
Tiotropium—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00199	0.00355	CcSEcCtD
Tiotropium—Angiopathy—Betamethasone—ankylosing spondylitis	0.00199	0.00355	CcSEcCtD
Tiotropium—Hypertension—Prednisolone—ankylosing spondylitis	0.00198	0.00352	CcSEcCtD
Tiotropium—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00196	0.0035	CcSEcCtD
Tiotropium—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00196	0.0035	CcSEcCtD
Tiotropium—Angioedema—Triamcinolone—ankylosing spondylitis	0.00192	0.00343	CcSEcCtD
Tiotropium—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00192	0.00342	CcSEcCtD
Tiotropium—Syncope—Triamcinolone—ankylosing spondylitis	0.00189	0.00337	CcSEcCtD
Tiotropium—Syncope—Methylprednisolone—ankylosing spondylitis	0.00188	0.00336	CcSEcCtD
Tiotropium—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00188	0.00335	CcSEcCtD
Tiotropium—Oedema—Prednisolone—ankylosing spondylitis	0.00187	0.00333	CcSEcCtD
Tiotropium—Dysuria—Methotrexate—ankylosing spondylitis	0.00187	0.00333	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00185	0.00331	CcSEcCtD
Tiotropium—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00185	0.0033	CcSEcCtD
Tiotropium—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00185	0.00329	CcSEcCtD
Tiotropium—Shock—Prednisolone—ankylosing spondylitis	0.00184	0.00328	CcSEcCtD
Tiotropium—Cough—Triamcinolone—ankylosing spondylitis	0.00184	0.00328	CcSEcCtD
Tiotropium—Tachycardia—Prednisolone—ankylosing spondylitis	0.00182	0.00325	CcSEcCtD
Tiotropium—Hypertension—Triamcinolone—ankylosing spondylitis	0.00182	0.00324	CcSEcCtD
Tiotropium—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00181	0.00323	CcSEcCtD
Tiotropium—Myalgia—Triamcinolone—ankylosing spondylitis	0.00179	0.0032	CcSEcCtD
Tiotropium—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00179	0.00319	CcSEcCtD
Tiotropium—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00179	0.00319	CcSEcCtD
Tiotropium—Eye disorder—Prednisone—ankylosing spondylitis	0.00179	0.00318	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00178	0.00317	CcSEcCtD
Tiotropium—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00175	0.00313	CcSEcCtD
Tiotropium—Renal failure—Methotrexate—ankylosing spondylitis	0.00175	0.00312	CcSEcCtD
Tiotropium—Angioedema—Dexamethasone—ankylosing spondylitis	0.00175	0.00311	CcSEcCtD
Tiotropium—Angioedema—Betamethasone—ankylosing spondylitis	0.00175	0.00311	CcSEcCtD
Tiotropium—Stomatitis—Methotrexate—ankylosing spondylitis	0.00173	0.00309	CcSEcCtD
Tiotropium—Angiopathy—Prednisone—ankylosing spondylitis	0.00173	0.00309	CcSEcCtD
Tiotropium—Immune system disorder—Prednisone—ankylosing spondylitis	0.00173	0.00308	CcSEcCtD
Tiotropium—Oedema—Triamcinolone—ankylosing spondylitis	0.00172	0.00306	CcSEcCtD
Tiotropium—Syncope—Betamethasone—ankylosing spondylitis	0.00171	0.00305	CcSEcCtD
Tiotropium—Syncope—Dexamethasone—ankylosing spondylitis	0.00171	0.00305	CcSEcCtD
Tiotropium—Arrhythmia—Prednisone—ankylosing spondylitis	0.00171	0.00304	CcSEcCtD
Tiotropium—Infection—Triamcinolone—ankylosing spondylitis	0.00171	0.00304	CcSEcCtD
Tiotropium—Infection—Methylprednisolone—ankylosing spondylitis	0.0017	0.00304	CcSEcCtD
Tiotropium—Shock—Triamcinolone—ankylosing spondylitis	0.00169	0.00301	CcSEcCtD
Tiotropium—Insomnia—Prednisolone—ankylosing spondylitis	0.00169	0.00301	CcSEcCtD
Tiotropium—Shock—Methylprednisolone—ankylosing spondylitis	0.00169	0.00301	CcSEcCtD
Tiotropium—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00168	0.003	CcSEcCtD
Tiotropium—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00168	0.00299	CcSEcCtD
Tiotropium—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00168	0.00299	CcSEcCtD
Tiotropium—Epistaxis—Methotrexate—ankylosing spondylitis	0.00168	0.00299	CcSEcCtD
Tiotropium—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00168	0.00299	CcSEcCtD
Tiotropium—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00168	0.00299	CcSEcCtD
Tiotropium—Mental disorder—Prednisone—ankylosing spondylitis	0.00167	0.00299	CcSEcCtD
Tiotropium—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00167	0.00298	CcSEcCtD
Tiotropium—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00167	0.00297	CcSEcCtD
Tiotropium—Malnutrition—Prednisone—ankylosing spondylitis	0.00166	0.00297	CcSEcCtD
Tiotropium—Hypertension—Betamethasone—ankylosing spondylitis	0.00165	0.00294	CcSEcCtD
Tiotropium—Hypertension—Dexamethasone—ankylosing spondylitis	0.00165	0.00294	CcSEcCtD
Tiotropium—Myalgia—Dexamethasone—ankylosing spondylitis	0.00163	0.0029	CcSEcCtD
Tiotropium—Myalgia—Betamethasone—ankylosing spondylitis	0.00163	0.0029	CcSEcCtD
Tiotropium—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00159	0.00283	CcSEcCtD
Tiotropium—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00158	0.00281	CcSEcCtD
Tiotropium—Vision blurred—Prednisone—ankylosing spondylitis	0.00157	0.0028	CcSEcCtD
Tiotropium—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00157	0.00279	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00157	0.00279	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00156	0.00279	CcSEcCtD
Tiotropium—Oedema—Betamethasone—ankylosing spondylitis	0.00156	0.00278	CcSEcCtD
Tiotropium—Oedema—Dexamethasone—ankylosing spondylitis	0.00156	0.00278	CcSEcCtD
Tiotropium—Insomnia—Triamcinolone—ankylosing spondylitis	0.00155	0.00277	CcSEcCtD
Tiotropium—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00155	0.00276	CcSEcCtD
Tiotropium—Infection—Betamethasone—ankylosing spondylitis	0.00155	0.00276	CcSEcCtD
Tiotropium—Infection—Dexamethasone—ankylosing spondylitis	0.00155	0.00276	CcSEcCtD
Tiotropium—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00154	0.00275	CcSEcCtD
Tiotropium—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00154	0.00275	CcSEcCtD
Tiotropium—Visual impairment—Methotrexate—ankylosing spondylitis	0.00154	0.00274	CcSEcCtD
Tiotropium—Shock—Betamethasone—ankylosing spondylitis	0.00153	0.00274	CcSEcCtD
Tiotropium—Shock—Dexamethasone—ankylosing spondylitis	0.00153	0.00274	CcSEcCtD
Tiotropium—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00153	0.00273	CcSEcCtD
Tiotropium—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00153	0.00273	CcSEcCtD
Tiotropium—Tachycardia—Betamethasone—ankylosing spondylitis	0.00152	0.00271	CcSEcCtD
Tiotropium—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00152	0.00271	CcSEcCtD
Tiotropium—Angioedema—Prednisone—ankylosing spondylitis	0.00152	0.00271	CcSEcCtD
Tiotropium—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00151	0.0027	CcSEcCtD
Tiotropium—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00151	0.00269	CcSEcCtD
Tiotropium—Eye disorder—Methotrexate—ankylosing spondylitis	0.00149	0.00266	CcSEcCtD
Tiotropium—Syncope—Prednisone—ankylosing spondylitis	0.00149	0.00266	CcSEcCtD
Tiotropium—Urticaria—Prednisolone—ankylosing spondylitis	0.00148	0.00265	CcSEcCtD
Tiotropium—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00146	0.00261	CcSEcCtD
Tiotropium—Angiopathy—Methotrexate—ankylosing spondylitis	0.00145	0.00258	CcSEcCtD
Tiotropium—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00144	0.00257	CcSEcCtD
Tiotropium—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00144	0.00257	CcSEcCtD
Tiotropium—Hypertension—Prednisone—ankylosing spondylitis	0.00144	0.00256	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00142	0.00253	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00142	0.00253	CcSEcCtD
Tiotropium—Myalgia—Prednisone—ankylosing spondylitis	0.00142	0.00253	CcSEcCtD
Tiotropium—Arthralgia—Prednisone—ankylosing spondylitis	0.00142	0.00253	CcSEcCtD
Tiotropium—Insomnia—Dexamethasone—ankylosing spondylitis	0.00141	0.00251	CcSEcCtD
Tiotropium—Insomnia—Betamethasone—ankylosing spondylitis	0.00141	0.00251	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00141	0.00251	CcSEcCtD
Tiotropium—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.0014	0.0025	CcSEcCtD
Tiotropium—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.0014	0.0025	CcSEcCtD
Tiotropium—Paraesthesia—Betamethasone—ankylosing spondylitis	0.0014	0.0025	CcSEcCtD
Tiotropium—Mental disorder—Methotrexate—ankylosing spondylitis	0.0014	0.0025	CcSEcCtD
Tiotropium—Malnutrition—Methotrexate—ankylosing spondylitis	0.00139	0.00248	CcSEcCtD
Tiotropium—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00138	0.00245	CcSEcCtD
Tiotropium—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00137	0.00245	CcSEcCtD
Tiotropium—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00137	0.00245	CcSEcCtD
Tiotropium—Urticaria—Triamcinolone—ankylosing spondylitis	0.00137	0.00243	CcSEcCtD
Tiotropium—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00136	0.00243	CcSEcCtD
Tiotropium—Oedema—Prednisone—ankylosing spondylitis	0.00136	0.00242	CcSEcCtD
Tiotropium—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00136	0.00242	CcSEcCtD
Tiotropium—Infection—Prednisone—ankylosing spondylitis	0.00135	0.00241	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00135	0.0024	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00135	0.0024	CcSEcCtD
Tiotropium—Back pain—Methotrexate—ankylosing spondylitis	0.00135	0.0024	CcSEcCtD
Tiotropium—Shock—Prednisone—ankylosing spondylitis	0.00134	0.00238	CcSEcCtD
Tiotropium—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00133	0.00237	CcSEcCtD
Tiotropium—Tachycardia—Prednisone—ankylosing spondylitis	0.00133	0.00236	CcSEcCtD
Tiotropium—Skin disorder—Prednisone—ankylosing spondylitis	0.00132	0.00235	CcSEcCtD
Tiotropium—Vision blurred—Methotrexate—ankylosing spondylitis	0.00131	0.00234	CcSEcCtD
Tiotropium—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00128	0.00227	CcSEcCtD
Tiotropium—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00128	0.00227	CcSEcCtD
Tiotropium—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00127	0.00226	CcSEcCtD
Tiotropium—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00126	0.00225	CcSEcCtD
Tiotropium—Urticaria—Dexamethasone—ankylosing spondylitis	0.00124	0.00221	CcSEcCtD
Tiotropium—Urticaria—Betamethasone—ankylosing spondylitis	0.00124	0.00221	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00124	0.00221	CcSEcCtD
Tiotropium—Dizziness—Prednisolone—ankylosing spondylitis	0.00124	0.0022	CcSEcCtD
Tiotropium—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00123	0.0022	CcSEcCtD
Tiotropium—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00123	0.0022	CcSEcCtD
Tiotropium—Insomnia—Prednisone—ankylosing spondylitis	0.00123	0.00219	CcSEcCtD
Tiotropium—Paraesthesia—Prednisone—ankylosing spondylitis	0.00122	0.00217	CcSEcCtD
Tiotropium—Pruritus—Triamcinolone—ankylosing spondylitis	0.00122	0.00217	CcSEcCtD
Tiotropium—Cough—Methotrexate—ankylosing spondylitis	0.00121	0.00216	CcSEcCtD
Tiotropium—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00121	0.00216	CcSEcCtD
Tiotropium—Dyspepsia—Prednisone—ankylosing spondylitis	0.0012	0.00213	CcSEcCtD
Tiotropium—Arthralgia—Methotrexate—ankylosing spondylitis	0.00118	0.00211	CcSEcCtD
Tiotropium—Myalgia—Methotrexate—ankylosing spondylitis	0.00118	0.00211	CcSEcCtD
Tiotropium—Chest pain—Methotrexate—ankylosing spondylitis	0.00118	0.00211	CcSEcCtD
Tiotropium—Rash—Prednisolone—ankylosing spondylitis	0.00118	0.0021	CcSEcCtD
Tiotropium—Dermatitis—Prednisolone—ankylosing spondylitis	0.00118	0.0021	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00118	0.0021	CcSEcCtD
Tiotropium—Headache—Prednisolone—ankylosing spondylitis	0.00117	0.00209	CcSEcCtD
Tiotropium—Constipation—Prednisone—ankylosing spondylitis	0.00116	0.00207	CcSEcCtD
Tiotropium—Dizziness—Triamcinolone—ankylosing spondylitis	0.00114	0.00203	CcSEcCtD
Tiotropium—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00113	0.00202	CcSEcCtD
Tiotropium—Infection—Methotrexate—ankylosing spondylitis	0.00113	0.00201	CcSEcCtD
Tiotropium—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00111	0.00198	CcSEcCtD
Tiotropium—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00111	0.00198	CcSEcCtD
Tiotropium—Nausea—Prednisolone—ankylosing spondylitis	0.00111	0.00198	CcSEcCtD
Tiotropium—Pruritus—Betamethasone—ankylosing spondylitis	0.0011	0.00197	CcSEcCtD
Tiotropium—Pruritus—Dexamethasone—ankylosing spondylitis	0.0011	0.00197	CcSEcCtD
Tiotropium—Skin disorder—Methotrexate—ankylosing spondylitis	0.0011	0.00197	CcSEcCtD
Tiotropium—Vomiting—Triamcinolone—ankylosing spondylitis	0.00109	0.00195	CcSEcCtD
Tiotropium—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00109	0.00194	CcSEcCtD
Tiotropium—Rash—Triamcinolone—ankylosing spondylitis	0.00108	0.00193	CcSEcCtD
Tiotropium—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00108	0.00193	CcSEcCtD
Tiotropium—Rash—Methylprednisolone—ankylosing spondylitis	0.00108	0.00193	CcSEcCtD
Tiotropium—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00108	0.00193	CcSEcCtD
Tiotropium—Urticaria—Prednisone—ankylosing spondylitis	0.00108	0.00192	CcSEcCtD
Tiotropium—Headache—Triamcinolone—ankylosing spondylitis	0.00108	0.00192	CcSEcCtD
Tiotropium—Headache—Methylprednisolone—ankylosing spondylitis	0.00107	0.00192	CcSEcCtD
Tiotropium—Abdominal pain—Prednisone—ankylosing spondylitis	0.00107	0.00191	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00103	0.00184	CcSEcCtD
Tiotropium—Dizziness—Betamethasone—ankylosing spondylitis	0.00103	0.00184	CcSEcCtD
Tiotropium—Dizziness—Dexamethasone—ankylosing spondylitis	0.00103	0.00184	CcSEcCtD
Tiotropium—Insomnia—Methotrexate—ankylosing spondylitis	0.00103	0.00183	CcSEcCtD
Tiotropium—Nausea—Triamcinolone—ankylosing spondylitis	0.00102	0.00182	CcSEcCtD
Tiotropium—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00102	0.00182	CcSEcCtD
Tiotropium—Nausea—Methylprednisolone—ankylosing spondylitis	0.00102	0.00182	CcSEcCtD
Tiotropium—Hypersensitivity—Prednisone—ankylosing spondylitis	0.001	0.00178	CcSEcCtD
Tiotropium—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000999	0.00178	CcSEcCtD
Tiotropium—Vomiting—Dexamethasone—ankylosing spondylitis	0.000991	0.00177	CcSEcCtD
Tiotropium—Vomiting—Betamethasone—ankylosing spondylitis	0.000991	0.00177	CcSEcCtD
Tiotropium—Rash—Dexamethasone—ankylosing spondylitis	0.000983	0.00175	CcSEcCtD
Tiotropium—Rash—Betamethasone—ankylosing spondylitis	0.000983	0.00175	CcSEcCtD
Tiotropium—Dermatitis—Betamethasone—ankylosing spondylitis	0.000982	0.00175	CcSEcCtD
Tiotropium—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000982	0.00175	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00098	0.00175	CcSEcCtD
Tiotropium—Headache—Dexamethasone—ankylosing spondylitis	0.000977	0.00174	CcSEcCtD
Tiotropium—Headache—Betamethasone—ankylosing spondylitis	0.000977	0.00174	CcSEcCtD
Tiotropium—Pruritus—Prednisone—ankylosing spondylitis	0.000961	0.00171	CcSEcCtD
Tiotropium—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000928	0.00165	CcSEcCtD
Tiotropium—Nausea—Dexamethasone—ankylosing spondylitis	0.000926	0.00165	CcSEcCtD
Tiotropium—Nausea—Betamethasone—ankylosing spondylitis	0.000926	0.00165	CcSEcCtD
Tiotropium—Urticaria—Methotrexate—ankylosing spondylitis	0.000902	0.00161	CcSEcCtD
Tiotropium—Dizziness—Prednisone—ankylosing spondylitis	0.000898	0.0016	CcSEcCtD
Tiotropium—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000897	0.0016	CcSEcCtD
Tiotropium—Vomiting—Prednisone—ankylosing spondylitis	0.000863	0.00154	CcSEcCtD
Tiotropium—Rash—Prednisone—ankylosing spondylitis	0.000856	0.00153	CcSEcCtD
Tiotropium—Dermatitis—Prednisone—ankylosing spondylitis	0.000855	0.00153	CcSEcCtD
Tiotropium—Headache—Prednisone—ankylosing spondylitis	0.000851	0.00152	CcSEcCtD
Tiotropium—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000836	0.00149	CcSEcCtD
Tiotropium—Nausea—Prednisone—ankylosing spondylitis	0.000807	0.00144	CcSEcCtD
Tiotropium—Pruritus—Methotrexate—ankylosing spondylitis	0.000803	0.00143	CcSEcCtD
Tiotropium—Dizziness—Methotrexate—ankylosing spondylitis	0.000751	0.00134	CcSEcCtD
Tiotropium—Vomiting—Methotrexate—ankylosing spondylitis	0.000722	0.00129	CcSEcCtD
Tiotropium—Rash—Methotrexate—ankylosing spondylitis	0.000716	0.00128	CcSEcCtD
Tiotropium—Dermatitis—Methotrexate—ankylosing spondylitis	0.000715	0.00127	CcSEcCtD
Tiotropium—Headache—Methotrexate—ankylosing spondylitis	0.000711	0.00127	CcSEcCtD
Tiotropium—Nausea—Methotrexate—ankylosing spondylitis	0.000674	0.0012	CcSEcCtD
